Kodiak Sciences Inc.
KOD
शेयरों में रैंक
#3155
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical... Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.
शेयर मूल्य
$90.83
अंतिम समन्वयन: 2026-10-19
मार्केट कैप
$5.71B
बदलाव (1 दिन)
5.92%
बदलाव (1 वर्ष)
413.16%
देश
US
व्यापार Kodiak Sciences Inc. (KOD)
श्रेणी
Healthcare
Kodiak Sciences Inc. (KOD) के लिए EPS
June 2026 TTM तक का EPS: $-4.19
Kodiak Sciences Inc. की नवीनतम वित्तीय रिपोर्टों और शेयर मूल्य के अनुसार, कंपनी का वर्तमान EPS (TTM) $-4.19 है। 2023 के अंत में, कंपनी का EPS $-4.97 था, जो 2022 के EPS $-6.39 के की तुलना में कमी था।
Kodiak Sciences Inc. के लिए 2016 से 2026 तक का EPS इतिहास
प्रत्येक वर्ष के अंत में EPS
| वर्ष | EPS | परिवर्तन |
|---|---|---|
| 2026 (TTM) | $-4.19 | 25.07% |
| 2024 | $-3.35 | -32.60% |
| 2023 | $-4.97 | -22.22% |
| 2022 | $-6.39 | 23.84% |
| 2021 | $-5.16 | 77.32% |
| 2020 | $-2.91 | 136.59% |
| 2019 | $-1.23 | 6.03% |
| 2018 | $-1.16 | 10.48% |
| 2017 | $-1.05 | -54.35% |
| 2016 | $-2.30 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए EPS
| कंपनी | EPS | EPS अंतर | देश |
|---|---|---|---|
| $17.32 | -513.37% |
US
|
|
| $-7.98 | 90.45% |
US
|
|
| $-5.29 | 26.25% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -762.05% |
NL
|
